Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

You're thinking of participating in a clinical trial – what now? Ask questions and weigh the risks before deciding if a clinical trial is right for you.

Paradigm Biopharmaceuticals has selected Advanced Clinical as the clinical research organisation (CRO) to support its pivotal ...

Paradigm Biopharmaceuticals continues to edge closer towards starting the pivotal phase III trial for its knee osteoarthritis ...

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

GH Research shares were up 801 to $19.15 after the company said the primary endpoint was met in a Phase 2b clinical trial with GH001, an inhalable mebufotenin product candidate, in patients with ...

Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

GH Research PLC announced positive results from a Phase 2b clinical trial of GH001, an inhalable treatment for treatment-resistant depression (TRD), demonstrating a significant placebo-adjusted ...

Paradigm Biopharmaceuticals has selected Advanced Clinical as the preferred clinical research organisation for the phase III trial for PARA_OA_012. Advanced Clinical has a proven track record in ...